|
ASCC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.600100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.057900E-03 |
| Normal-vs-Stage2 |
1.076040E-01 |
| Normal-vs-Stage3 |
1.619400E-01 |
| Normal-vs-Stage4 |
1.047210E-01 |
| Stage1-vs-Stage2 |
8.383600E-01 |
| Stage1-vs-Stage3 |
1.372360E-01 |
| Stage1-vs-Stage4 |
5.077600E-01 |
| Stage2-vs-Stage3 |
5.252200E-01 |
| Stage2-vs-Stage4 |
7.862200E-01 |
| Stage3-vs-Stage4 |
6.638600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.861000E-03 |
| Normal-vs-AfricanAmerican |
7.810200E-01 |
| Normal-vs-Asian |
1.006250E-01 |
| Caucasian-vs-AfricanAmerican |
2.125600E-02 |
| Caucasian-vs-Asian |
6.191200E-01 |
| AfricanAmerican-vs-Asian |
1.520630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.043780E-02 |
| Normal-vs-Female |
1.220200E-02 |
| Male-vs-Female |
8.577200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.554190E-01 |
| Normal-vs-Age(41-60Yrs) |
4.940600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.949900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.203200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.992800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.737800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.723750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.611000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.230770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.584040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.166460E-02 |
| Normal-vs-Grade 2 |
9.240300E-04 |
| Normal-vs-Grade 3 |
1.393390E-01 |
| Normal-vs-Grade 4 |
1.113760E-01 |
| Grade 1-vs-Grade 2 |
5.163400E-01 |
| Grade 1-vs-Grade 3 |
6.096200E-02 |
| Grade 1-vs-Grade 4 |
3.655400E-01 |
| Grade 2-vs-Grade 3 |
1.225770E-02 |
| Grade 2-vs-Grade 4 |
4.147200E-01 |
| Grade 3-vs-Grade 4 |
4.824200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.180330E-03 |
| Normal-vs-ccB subtype |
8.684000E-03 |
| ccA subtype-vs-ccB subtype |
5.836400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.199200E-03 |
| Normal-vs-N1 |
2.044800E-01 |
| N0-vs-N1 |
5.068800E-01 |
|
|
